This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Ott E, Graf K, Schwab F, Reichardt C, Chaberny IF.Costs of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. 19th European Congress of Clinical Microbiology and Infectious Diseases: abstr. 86419, 19 May 2009. Available from: URL: http://www.akm.ch/eccmid2009
Wassenberg M, de Wit A, van der Zanden B, Bonten M.Cost analysis of rapid diagnostic testing of methicillin-resistant Staphylococcus aureus using PCR or chromogenic agar in a low endemic setting. 19th European Congress of Clinical Microbiology and Infectious Diseases: abstr. 82368, 19 May 2009. Available from: URL: http://www.akm.ch/eccmid2009
Murthy A, De Angelis G, PITTET D, Schrenzel J, HARBARTH S.Cost-effectiveness analysis of universal rapid screening for methicillin-resistant Staphylococcus aureus at hospital admission. 19th European Congress of Clinical Microbiology and Infectious Diseases: abstr. 86077, 17 May 2009. Available from: URL: http://www.akm.ch/eccmid2009
Rights and permissions
About this article
Cite this article
MRSA financial burden high, but rapid screening could help. Pharmacoecon. Outcomes News 580, 8 (2009). https://doi.org/10.2165/00151234-200905800-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905800-00017